Riskpilot← Back to searchSign inGet full accessSIMED AS
ASActiveOrg 992215917Doktor Holms Vei 19D, 0787 OsloAllmenn legetjeneste · NACE 86211Est. 20081 employeeswww.avivahelse.no
Revenue 2021
NOK 2,7M
-71% vs 2020
EBITDA margin
13.4%
+77% vs 2020
Equity ratio
45.7%
Financial strength
Net profit 2021
NOK 654K
+87% vs 2020
| Revenue | NOK 2,7M | -71% |
| EBITDA | NOK 356K | +77% |
| Net profit | NOK 654K | +87% |
| Total assets | NOK 4,2M | +9% |
| Equity | NOK 1,9M | +2219% |
| Employees | 1 | — |
Legal name
SIMED AS
Org number
992215917
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
29. januar 2008
Share capital
NOK 50 000 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Eie og drive medisinsk klinikkvirksomhet som leverandør av helsetjenester rettet mot private og offentlige personer og institusjoner.
Address
Doktor Holms Vei 19D, 0787 Oslo
Website
www.avivahelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 545 | 0 | 0 | 16 964 | 17 233 | 16 178 | 13 009 | 11 006 | 12 283 | 12 293 | 12 202 | 11 766 | 9 302 | 2 652 |
| Staff expenses | −1 986 | −0 | −0 | −1 249 | −3 702 | −4 060 | −3 887 | −3 536 | −2 409 | −2 228 | −2 820 | −2 718 | −1 682 | −1 564 |
| EBITDA | −2 788 | 0 | 0 | 3 752 | 3 403 | 1 450 | 181 | −912 | 1 876 | 2 375 | 2 044 | 2 027 | 201 | 356 |
| Depreciation & amort. | −41 | −0 | −0 | −72 | −130 | −345 | −1 397 | −2 532 | −2 519 | −2 456 | −2 305 | −1 242 | −0 | −0 |
| EBIT | −2 829 | 0 | 0 | 3 680 | 3 273 | 1 105 | −1 217 | −3 444 | −643 | −81 | −261 | 785 | 201 | 356 |
| Net financials | 109 | 0 | 0 | 188 | 289 | 243 | −175 | −339 | −328 | −224 | −179 | −140 | −39 | −30 |
| Profit before tax | −2 721 | 0 | 0 | 3 868 | 3 562 | 1 347 | −1 392 | −3 783 | −972 | −305 | −441 | 645 | 161 | 325 |
| Tax | 3 | −0 | −0 | 544 | 1 157 | 442 | −0 | −23 | −265 | −0 | −0 | −0 | −188 | −329 |
| Net profit | −2 723 | 0 | 0 | 3 324 | 2 405 | 906 | −1 392 | −3 760 | −707 | −305 | −441 | 645 | 349 | 654 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 904 | — | — | 8 063 | 12 201 | 8 706 | 15 064 | 11 312 | 9 757 | 6 969 | 6 537 | 2 905 | 3 823 | 4 161 |
| Equity | 1 293 | — | — | 6 356 | 3 261 | 4 167 | 2 775 | −922 | −832 | −1 137 | −1 578 | −933 | 82 | 1 902 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 10 048 | 9 669 | 9 326 | 6 760 | 6 955 | 3 161 | 2 747 | 1 931 |
| Short-term debt | 612 | 0 | 0 | 1 694 | 8 940 | 4 539 | 2 241 | 2 565 | 1 263 | 1 346 | 1 159 | 677 | 994 | 328 |
| Total debt | 612 | 0 | 0 | 1 707 | 8 940 | 4 539 | 12 289 | 12 233 | 10 589 | 8 106 | 8 115 | 3 838 | 3 741 | 2 259 |
EBITDA margin
13.4%
This company
15.8%
Market median
-15% vs market
20082021
Equity ratio
45.7%
This company
38.2%
Market median
+20% vs market
20082021
Return on equity
34.4%
This company
18.4%
Market median
+87% vs market
20082021
Net profit margin
24.7%
This company
8.1%
Market median
+205% vs market
20082021
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20082021
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20082021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-11-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2007-11-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HV Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SIMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halfdan Vier Simensen | Chief Executive Officer | 0 companies |
| Mona Kristin Hellund-Angerer | Chairman | 0 companies |